Non-Opioid Therapies for Pain Management in the ED
The use of non-opioid analgesic therapies is increasing among ED physicians.
Acute Pain
ACUTE PAIN
Feature Article
Latest
Leveraging Virtual Reality Technology for Acute Pain
Virtual reality technology may be useful in such areas as exposure therapy and pain management.
Use by Paramedics of Intranasal Ketamine Plus Nitrous Oxide May Alleviate Acute Pain
The addition of intranasal ketamine, administered by paramedics, to usual treatment with nitrous oxide was found to alleviate acute pain and improve comfort within 30 minutes.
Robust Evidence Supports Analgesic, Antihyperalgesic Properties of Ketamine
There is solid evidence supporting the notion that ketamine may have analgesic and antihyperalgesic properties.
Predicting Time to Pain Resolution, Recovery, and Opioid Cessation After Surgery
In surgical patients, time to pain resolution, complete recovery from surgery, and opioid cessation were found to be predicted by the worst pain occurring 10 days after surgery.
Six Trajectories Identified for Acute Pain Post-Emergency Department Visit
The researchers identified 6 distinct trajectories for the resolution of acute pain after discharge from the emergency department.
Opioid Prescription of 4 to 7 Days May Be Sufficient for Acute Pain Management
An initial prescription of opioids for 4 to 7 days for the management of acute pain in the primary care setting was found to be sufficient.
Second Complete Response Letter Issued for IV Meloxicam
The Food and Drug Administration (FDA) has sent a second Complete Response Letter to Recro Pharma concerning their New Drug Application for intravenous meloxicam.
Four-to-Seven-Day Opioid Prescription Likely Sufficient for Acute Pain Treatment
An opioid supply for seven or fewer days might be sufficient for most patients seen in primary care settings for acute pain who appear to need opioid analgesics.
Authorized Generic of Flector Patch Now Available From Teva
An authorized generic of Flector Patch (diclofenac epolamine topical patch) has been made available by Teva Pharmaceuticals for the topical treatment of acute pain due to minor strains, sprains, and contusions.
New Drug Combination May Be An Effective Prophylactic for Opioid-Induced Nausea
CL-108, a new combination of a low-dose antiemetic with hydrocodone and acetaminophen, may be a safe and effective prophylactic medication for the treatment of opioid-induced nausea and vomiting in individuals treated for moderate to severe acute pain.
Want to read more?
Please login or register first to view this content.
Next post in Acute Pain
